A Trial to Assess a Wearable Patch's Functioning to Detect Medication Ingestion
Study Identifier:
031-201-00521
ClinicalTrials.gov Identifier:
EudraCT Identifier:
N/A
Sponsor:
Otsuka Pharmaceutical Development & Commercialization, Inc.
Study Contact Information:
N/A
Study Complete
Results Available
Study Protocol
Available Languages: English
Statistical Analysis Plan
Available Languages: English
Study Details
Medical Condition
- Mental disorder
- Schizophrenia
- Depression
- Bipolar Disorder
Study Drug
- Drug: Placebo IEM tablet
- Drug: Abilify MyCite®
Date
Jun 2023 - Jul 2023
Phase 1/2
Phase 2/3
Phase 1
Phase 2
Phase 3
Phase 4
N/A
Patient Requirements
Sex: Female & Male
Age: 18+ years
Requirements Information
Protocol Summary
The primary purpose of the study is to evaluate the positive detection accuracy (PDA) and detection latency measures of the D-Tect patch.
Study Locations
Location
Status
Location
Research site
Garden Grove, California, United States, 92845
Status
N/A